{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:23Z","timestamp":1707525023643},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,9]]},"DOI":"10.7759\/cureus.35965","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T06:37:52Z","timestamp":1678430272000},"source":"Crossref","is-referenced-by-count":1,"title":["Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype"],"prefix":"10.7759","author":[{"given":"Sindhura Lakshmi","family":"Koulmane Laxminarayana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saksham","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhalak","family":"Agrohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Belurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-014-0413-1","article-title":"Clinical and hematological profile of acute megakaryoblastic leukemia: a 2\u00a0year study","volume":"31","author":"Jayasudha AV","year":"2015","unstructured":"Jayasudha AV, Nair RA, Jacob PM, et al.. Clinical and hematological profile of acute megakaryoblastic leukemia: a 2\u00a0year study. Indian J Hematol Blood Transfus. 2015, 31:169-73. 10.1007\/s12288-014-0413-1","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/461912","article-title":"Clinico-haematological profile of acute megakaryoblastic leukaemia: report of five cases","volume":"2009","author":"Sharma S","year":"2009","unstructured":"Sharma S, Nangia A, Jain Malhotra S, Narayan S, Harbhajanka A, Singh S. Clinico-haematological profile of acute megakaryoblastic leukaemia: report of five cases. Adv Hematol. 2009, 2009:461912. 10.1155\/2009\/461912","journal-title":"Adv Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-35762-3.00062-7","article-title":"Acute myeloid leukemia in children","author":"Gruber TA","year":"2018","unstructured":"Gruber TA, Rubnitz JE. Acute myeloid leukemia in children. Hematology. 2018, 981-3. 10.1016\/b978-0-323-35762-3.00062-7","journal-title":"Hematology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.07.011","article-title":"Acute leukemias in children with Down syndrome","volume":"107","author":"Seewald L","year":"2012","unstructured":"Seewald L, Taub JW, Maloney KW, McCabe ER. Acute leukemias in children with Down syndrome. Mol Genet Metab. 2012, 107:25-30. 10.1016\/j.ymgme.2012.07.011","journal-title":"Mol Genet Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06971.x","article-title":"Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome","volume":"140","author":"Hama A","year":"2008","unstructured":"Hama A, Yagasaki H, Takahashi Y, et al.. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome. Br J Haematol. 2008, 140:552-61. 10.1111\/j.1365-2141.2007.06971.x","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3772","article-title":"Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes","volume":"49","author":"de Rooij JD","year":"2017","unstructured":"de Rooij JD, Branstetter C, Ma J, et al.. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. Nat Genet. 2017, 49:451-6. 10.1038\/ng.3772","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-118810","article-title":"Treatment and prognostic impact of transient leukemia in neonates with Down syndrome","volume":"111","author":"Klusmann JH","year":"2008","unstructured":"Klusmann JH, Creutzig U, Zimmermann M, et al.. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008, 111:2991-8. 10.1182\/blood-2007-10-118810","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2005.10.008","article-title":"GATA1 mutations in acute leukemia in children with Down syndrome","volume":"166","author":"Magalh\u00e3es IQ","year":"2006","unstructured":"Magalh\u00e3es IQ, Splendore A, Emerenciano M, Figueiredo A, Ferrari I, Pombo-de-Oliveira MS. GATA1 mutations in acute leukemia in children with Down syndrome. Cancer Genet Cytogenet. 2006, 166:112-6. 10.1016\/j.cancergencyto.2005.10.008","journal-title":"Cancer Genet Cytogenet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-414755","article-title":"Clinical characteristics and outcome of refractory\/relapsed myeloid leukemia in children with Down syndrome","volume":"120","author":"Taga T","year":"2012","unstructured":"Taga T, Saito AM, Kudo K, et al.. Clinical characteristics and outcome of refractory\/relapsed myeloid leukemia in children with Down syndrome. Blood. 2012, 120:1810-5. 10.1182\/blood-2012-03-414755","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20066","article-title":"GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia","volume":"44","author":"Crispino JD","year":"2005","unstructured":"Crispino JD. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer. 2005, 44:40-4. 10.1002\/pbc.20066","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"Wechsler J","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002, 32:148-52. 10.1038\/ng955","journal-title":"Nat Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.1.245","article-title":"Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome","volume":"99","author":"Zwaan CM","year":"2002","unstructured":"Zwaan CM, Kaspers GJ, Pieters R, et al.. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood. 2002, 99:245-51. 10.1182\/blood.v99.1.245","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2759","article-title":"The landscape of somatic mutations in Down syndrome-related myeloid disorders","volume":"45","author":"Yoshida K","year":"2013","unstructured":"Yoshida K, Toki T, Okuno Y, et al.. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet. 2013, 45:1293-9. 10.1038\/ng.2759","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-836510","article-title":"Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts","volume":"217","author":"Langebrake C","year":"2005","unstructured":"Langebrake C, Creutzig U, Reinhardt D. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts. Klin Padiatr. 2005, 217:126-34. 10.1055\/s-2005-836510","journal-title":"Klin Padiatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061583","article-title":"Immunophenotypic analysis of acute megakaryoblastic leukemia: a EuroFlow study","volume":"14","author":"Brouwer N","year":"2022","unstructured":"Brouwer N, Matarraz S, Nierkens S, et al.. Immunophenotypic analysis of acute megakaryoblastic leukemia: a EuroFlow study. Cancers (Basel). 2022, 14:1583. 10.3390\/cancers14061583","journal-title":"Cancers (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.04.011","article-title":"The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children","volume":"138","author":"Masetti R","year":"2019","unstructured":"Masetti R, Guidi V, Ronchini L, Bertuccio NS, Locatelli F, Pession A. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children. Crit Rev Oncol Hematol. 2019, 138:132-8. 10.1016\/j.critrevonc.2019.04.011","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2383-2","article-title":"Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial","volume":"94","author":"Schweitzer J","year":"2015","unstructured":"Schweitzer J, Zimmermann M, Rasche M, et al.. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Ann Hematol. 2015, 94:1327-36. 10.1007\/s00277-015-2383-2","journal-title":"Ann Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/133275-pediatric-non-down-syndrome-acute-megakaryoblastic-leukemia-with-unusual-immunophenotype","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:19Z","timestamp":1707508459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/133275-pediatric-non-down-syndrome-acute-megakaryoblastic-leukemia-with-unusual-immunophenotype"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.35965","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,9]]}}}